BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24321521)

  • 1. Significance of Akt activation and AKT gene increases in soft tissue tumors.
    Dobashi Y; Sato E; Oda Y; Inazawa J; Ooi A
    Hum Pathol; 2014 Jan; 45(1):127-36. PubMed ID: 24321521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations in AKT and its protein activation in human lung carcinomas.
    Dobashi Y; Kimura M; Matsubara H; Endo S; Inazawa J; Ooi A
    Hum Pathol; 2012 Dec; 43(12):2229-40. PubMed ID: 22748472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas.
    Dobashi Y; Tsubochi H; Matsubara H; Inoue J; Inazawa J; Endo S; Ooi A
    Cancer Sci; 2015 Jun; 106(6):772-781. PubMed ID: 25855050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
    Dobashi Y; Suzuki S; Sugawara H; Ooi A
    Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
    Iamaroon A; Krisanaprakornkit S
    Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancer.
    Li J; Su W; Zhang S; Hu Y; Liu J; Zhang X; Bai J; Yuan W; Hu L; Cheng T; Zetterberg A; Lei Z; Zhang J
    Cancer Sci; 2015 May; 106(5):642-9. PubMed ID: 25702787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
    Heidenblad M; Hallor KH; Staaf J; Jönsson G; Borg A; Höglund M; Mertens F; Mandahl N
    Oncogene; 2006 Nov; 25(53):7106-16. PubMed ID: 16732325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.
    Watson KL; Moorehead RA
    BMC Cancer; 2013 Aug; 13():375. PubMed ID: 23919516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression.
    Spears M; Cunningham CA; Taylor KJ; Mallon EA; Thomas JS; Kerr GR; Jack WJ; Kunkler IH; Cameron DA; Chetty U; Bartlett JM
    J Pathol; 2012 Aug; 227(4):481-9. PubMed ID: 22430898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of CREB by Akt1 and Akt2.
    Kato S; Ding J; Du K
    Biochem Biophys Res Commun; 2007 Mar; 354(4):1061-6. PubMed ID: 17276404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
    Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
    J Surg Res; 2007 Nov; 143(1):20-6. PubMed ID: 17950068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
    Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.
    Massion PP; Taflan PM; Shyr Y; Rahman SM; Yildiz P; Shakthour B; Edgerton ME; Ninan M; Andersen JJ; Gonzalez AL
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1088-94. PubMed ID: 15317667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.